Vera Therapeutics (NASDAQ:VERA) Given “Buy” Rating at HC Wainwright
HC Wainwright reissued their buy rating on shares of Vera Therapeutics (NASDAQ:VERA – Free Report) in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has a $25.00 price objective on the stock. Several other research analysts have also recently issued reports on VERA. Raymond James started coverage on Vera Therapeutics in […]
More Stories
Focus Partners Wealth Invests $193,000 in D-Wave Quantum Inc. (NYSE:QBTS)
Focus Partners Wealth purchased a new position in D-Wave Quantum Inc. (NYSE:QBTS – Free Report) during the 4th quarter, Holdings...
Sanford C. Bernstein Cuts Palo Alto Networks (NASDAQ:PANW) Price Target to $225.00
Palo Alto Networks (NASDAQ:PANW – Free Report) had its target price cut by Sanford C. Bernstein from $229.00 to $225.00...
Home Depot (NYSE:HD) Upgraded at Stifel Nicolaus
Stifel Nicolaus upgraded shares of Home Depot (NYSE:HD – Free Report) from a hold rating to a buy rating in...
Deutsche Bank AG Acquires 15,258 Shares of Enerpac Tool Group Corp. (NYSE:EPAC)
Deutsche Bank AG raised its holdings in shares of Enerpac Tool Group Corp. (NYSE:EPAC – Free Report) by 45.8% during...
Janus Henderson Group PLC Has $888,000 Stock Position in GFL Environmental Inc. (NYSE:GFL)
Janus Henderson Group PLC reduced its holdings in shares of GFL Environmental Inc. (NYSE:GFL – Free Report) by 77.0% in...
CleanSpark, Inc. (NASDAQ:CLSK) Shares Acquired by Janus Henderson Group PLC
Janus Henderson Group PLC lifted its position in shares of CleanSpark, Inc. (NASDAQ:CLSK – Free Report) by 10.1% during the...